Longevity
NKGen Biotech takes Alzheimer’s research global
As experimental cell therapy heads to BIOCHINA, company tests whether personalized treatment could reshape future of neurodegenerative care. What if one cellular therapy could one day be used against not just Alzheimer’s disease, but Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) as well? That’s the question emerging around NKGen Biotech as the […] The post NKGen Biotech takes Alzheimer’s research global appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →